{"id":5216,"date":"2021-01-28T09:12:28","date_gmt":"2021-01-28T08:12:28","guid":{"rendered":"https:\/\/staybletherapeutics.com\/sv\/?p=5216"},"modified":"2021-01-28T09:12:28","modified_gmt":"2021-01-28T08:12:28","slug":"inside-stayble-januari-2021","status":"publish","type":"post","link":"https:\/\/staybletherapeutics.com\/sv\/presentationer\/inside-stayble-januari-2021\/","title":{"rendered":"Inside Stayble: Januari 2021"},"content":{"rendered":"<p style=\"font-weight: 400;\">I januari 2021 uppdateringen ger VD Andreas Gerward uppdatering kring den p\u00e5g\u00e5ende fas 2b studien, senaste diskussionerna med potentiella partners samt information kring Bolagets kommande f\u00f6retr\u00e4desemission.<\/p>\n<p style=\"font-weight: 400;\">Inside Stayble \u00e4r en kommunikationskanal f\u00f6r att ge aktie\u00e4gare m\u00e5nadsvisa uppdateringar om Stayble Therapeutics och det kliniska utvecklingsprogrammet f\u00f6r STA363 i kronisk l\u00e4ndryggssm\u00e4rta.<\/p>\n<p style=\"font-weight: 400;\">Stayble Therapeutics \u00e4r listat p\u00e5 Nasdaq First North (STABL).<\/p>\n<p style=\"font-weight: 400;\">L\u00e4s mer p\u00e5\u00a0<a href=\"http:\/\/staybletherapeutics.se\/\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=http:\/\/staybletherapeutics.se&amp;source=gmail&amp;ust=1611906632544000&amp;usg=AFQjCNFwS9g5cLWS_WtdIMY3va9VMMSoFQ\">staybletherapeutics.se<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>I januari 2021 uppdateringen ger VD Andreas Gerward uppdatering kring den p\u00e5g\u00e5ende fas 2b studien, senaste diskussionerna med potentiella partners samt information kring Bolagets kommande f\u00f6retr\u00e4desemission. Inside Stayble \u00e4r en&#8230;<\/p>\n","protected":false},"author":1,"featured_media":5178,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts\/5216"}],"collection":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/comments?post=5216"}],"version-history":[{"count":1,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts\/5216\/revisions"}],"predecessor-version":[{"id":5218,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts\/5216\/revisions\/5218"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media\/5178"}],"wp:attachment":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=5216"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/categories?post=5216"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/tags?post=5216"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}